S'abonner

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology - 29/07/21

Doi : 10.1016/S1473-3099(20)30784-2 
Martin Hoenigl, MD a, b, c, az, , Jon Salmanton-García, PhD e, f, Thomas J Walsh, ProfMD i, j, Marcio Nucci, MD k, Chin Fen Neoh, PhD l, Jeffrey D Jenks, MD b, c, d, Michaela Lackner, PhD m, Rosanne Sprute, MD e, h, Abdullah M S Al-Hatmi, PhD n, Matteo Bassetti, ProfMD o, Fabianne Carlesse, MD p, Tomas Freiberger, MD q, Philipp Koehler, MD e, f, h, r, Thomas Lehrnbecher, MD s, Anil Kumar, ProfMD t, Juergen Prattes, MD a, Malcolm Richardson, ProfPhD u, v, Sanjay Revankar, MD w, Monica A Slavin, ProfMD x, y, Jannik Stemler, MD e, h, Birgit Spiess, PhD z, Saad J Taj-Aldeen, PhD aa, Adilia Warris, MD ab, Patrick C Y Woo, MD ac, Jo-Anne H Young, ProfMD ad, Kerstin Albus, MSc e, f, Dorothee Arenz, PhD e, f, ae, Valentina Arsic-Arsenijevic, MD af, az, Jean-Philippe Bouchara, PhD ag, Terrence Rohan Chinniah, MD ah, Anuradha Chowdhary, MD ai, G Sybren de Hoog, PhD ak, George Dimopoulos, MD al, Rafael F Duarte, MD am, Petr Hamal, MD an, az, Jacques F Meis, ProfMD aj, ak, az, Sayoki Mfinanga, MD ao, ap, aq, ar, Flavio Queiroz-Telles, MD as, Thomas F Patterson, ProfMD at, Galia Rahav, MD au, Thomas R Rogers, MD av, Coleman Rotstein, MD aw, Retno Wahyuningsih, MD ax, ay, Danila Seidel, PhD e, f, h, Oliver A Cornely, ProfMD e, f, g, h, az
a Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria 
b Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA, USA 
c Clinical and Translational Fungal Research Working Group, University of California San Diego, San Diego, CA, USA 
d Division of General Internal Medicine, Department of Medicine, University of California San Diego, San Diego, CA, USA 
e Faculty of Medicine, University of Cologne, Cologne, Germany 
f Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany 
g Clinical Trials Center Cologne, University of Cologne, Cologne, Germany 
h German Centre for Infection Research, partner site Bonn-Cologne, Cologne, Germany 
i Department of Medicine, Department of Pediatrics, and Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA 
j New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA 
k Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil 
l Faculty of Pharmacy, and Collaborative Drug Discovery Research Group, Pharmaceutical and Life Sciences, Community of Research, Universiti Teknologi MARA, Selangor, Malaysia 
m Institute of Hygiene and Medical Microbiology, Department of Hygiene, Medical Microbiology and Publics Health, Medical University Innsbruck, Innsbruck, Austria 
n Department of Microbiology, Natural & Medical Sciences Research Center, University of Nizwa, Nizwa, Oman 
o Division of Infections Diseases, Department of Health Sciences, IRCCS San Martino Polyclinic Hospital, University of Genoa, Genoa, Italy 
p Department of Pediatrics, and Pediatric Oncology Institute IOP-GRAACC-UNIFESP, Federal Univeristy of São Paulo, São Paulo, Brazil 
q Centre for Cardiovascular Surgery and Transplantation, and Faculty of Medicine, Masaryk University, Brno, Czech Republic 
r Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany 
s Division of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, University Hospital, Frankfurt, Germany 
t Department of Microbiology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, India 
u Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK 
v Mycology Reference Centre Manchester, Manchester University NHS Foundation Trust, Manchester, UK 
w Division of Infectious Diseases, Wayne State University, Detroit, MI, USA 
x University of Melbourne, Melbourne, VIC, Australia 
y National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 
z Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany 
aa Department of Laboratory Medicne and Pathology, Hamad Medical Corporation, Doha, Qatar 
ab Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK 
ac Department of Microbiology, University of Hong Kong, Hong Kong, China 
ad University of Minnesota, Minneapolis, MN, USA 
ae Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany 
af National Reference Laboratory for Medical Mycology, Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia 
ag Host-Pathogen Interaction Study Group, and Laboratory of Parasitology and Mycology, Angers University Hospital, Angers University, Angers, France 
ah Department of Microbiology, University of Colombo, Colombo, Sri Lanka 
ai Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India 
aj Department of Medical Microbiology and Infectious Diseases, Radboud University Medical Center-Canisius Wilhelmina Hospital, Nijmegen, Netherlands 
ak Center of Expertise in Mycology, Radboud University Medical Center-Canisius Wilhelmina Hospital, Nijmegen, Netherlands 
al Critical Care Department, Attikon University Hospital, National and Kapodistrian University of Athens, Greece 
am University Hospital Puerta de Hierro Majadahonda, Madrid, Spain 
an Department of Microbiology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic 
ao National Institute for Medical Research, Tanzania 
ap Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania 
aq Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania 
ar Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK 
as Department of Public Health, Clinics Hospital, Federal University of Parana, Curitiba, Brazil 
at UT Health San Antonio and South Texas Veterans Health Care System, San Antonio, TX, USA 
au Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 
av Department of Clinical Microbiology, Trinity College Dublin, St James’s Hospital Campus, Dublin, Ireland 
aw Division of Infectious Diseases, University of Toronto, Toronto, ON, Canada 
ax Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia 
ay Department of Parasitology, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia 
az European Confederation of Medical Mycology Council, Basel, Switzerland 

* Correspondence to: Dr Martin Hoenigl, Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, CA 92103, USA Division of Infectious Diseases and Global Public Health Department of Medicine University of California San Diego CA 92103 USA

Summary

With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World—One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.

Le texte complet de cet article est disponible en PDF.

Plan


© 2021  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 21 - N° 8

P. e246-e257 - août 2021 Retour au numéro
Article précédent Article précédent
  • Clinical interventions for tungiasis (sand flea disease): a systematic review
  • Solomon Abrha, Jorg Heukelbach, Gregory M Peterson, Julia K Christenson, Simon Carroll, Sam Kosari, Andrew Bartholomeus, Hermann Feldmeier, Jackson Thomas
| Article suivant Article suivant
  • Isolated pelvic bone involvement as a presentation of alveolar echinococcosis
  • Audrey Cambier, Marie-Pierre Hayette, Philippe Léonard, William Kurth, Pierre Lovinfosse, Jean-Baptiste Giot

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.